Back to All Events
CEO Ulla Buhl and CMO Peter Buhl attended ASCO 2024 to present a poster on AIDA Oncology’s AI model that can predict epirubicin response in breast cancer patient
Previous
Previous
March 1
AIDA joins BII Venture Lab
Next
Next
March 6